These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 12540215
21. Role of the osteoclast in cranial suture waveform patterning. Byron CD. Anat Rec A Discov Mol Cell Evol Biol; 2006 May; 288(5):552-63. PubMed ID: 16604542 [Abstract] [Full Text] [Related]
22. Attenuation of osteoclastogenesis and osteoclast function by apigenin. Bandyopadhyay S, Lion JM, Mentaverri R, Ricupero DA, Kamel S, Romero JR, Chattopadhyay N. Biochem Pharmacol; 2006 Jul 14; 72(2):184-97. PubMed ID: 16750176 [Abstract] [Full Text] [Related]
23. Effects of Porphyromonas gingivalis 2561 extracts on osteogenic and osteoclastic cell function in co-culture. Loomer PM, Ellen RP, Tenenbaum HC. J Periodontol; 1998 Nov 14; 69(11):1263-70. PubMed ID: 9848536 [Abstract] [Full Text] [Related]
24. Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH. Bone; 2004 Mar 14; 34(3):412-24. PubMed ID: 15003789 [Abstract] [Full Text] [Related]
25. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M. Bone; 2004 Nov 14; 35(5):1144-56. PubMed ID: 15542040 [Abstract] [Full Text] [Related]
26. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W. Bone; 2006 Aug 14; 39(2):325-35. PubMed ID: 16580896 [Abstract] [Full Text] [Related]
27. The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins. Hong MH, Williams H, Jin CH, Pike JW. J Bone Miner Res; 2000 May 14; 15(5):911-8. PubMed ID: 10804021 [Abstract] [Full Text] [Related]
28. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC. J Cell Physiol; 2005 Jun 14; 203(3):573-82. PubMed ID: 15573398 [Abstract] [Full Text] [Related]
29. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L. Arthritis Rheum; 2005 Sep 14; 52(9):2708-18. PubMed ID: 16142752 [Abstract] [Full Text] [Related]
30. Collinin reduces Porphyromonas gingivalis growth and collagenase activity and inhibits the lipopolysaccharide-induced macrophage inflammatory response and osteoclast differentiation and function. Santos J, Marquis A, Epifano F, Genovese S, Curini M, Grenier D. J Periodontol; 2013 May 14; 84(5):704-11. PubMed ID: 22897650 [Abstract] [Full Text] [Related]
31. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. de Vries TJ, Schoenmaker T, Beertsen W, van der Neut R, Everts V. J Cell Biochem; 2005 Apr 01; 94(5):954-66. PubMed ID: 15578568 [Abstract] [Full Text] [Related]
32. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH. Kwak HB, Lee SW, Li YJ, Kim YA, Han SY, Jhon GJ, Kim HH, Lee ZH. Biochem Pharmacol; 2004 Apr 01; 67(7):1239-48. PubMed ID: 15013839 [Abstract] [Full Text] [Related]
33. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Gorny G, Shaw A, Oursler MJ. Exp Cell Res; 2004 Mar 10; 294(1):149-58. PubMed ID: 14980510 [Abstract] [Full Text] [Related]
34. Substance P increases production of proinflammatory cytokines and formation of osteoclasts in dental pulp fibroblasts in patients with severe orthodontic root resorption. Yamaguchi M, Ozawa Y, Mishima H, Aihara N, Kojima T, Kasai K. Am J Orthod Dentofacial Orthop; 2008 May 10; 133(5):690-8. PubMed ID: 18456142 [Abstract] [Full Text] [Related]
35. The gingipains from Porphyromonas gingivalis do not directly induce osteoclast differentiation in primary mouse bone marrow cultures. Fitzpatrick RE, Campbell PD, Sivagurunathan S, Pagel CN, Potempa J, Mackie EJ, Pike RN. J Periodontal Res; 2009 Aug 10; 44(4):565-7. PubMed ID: 18717779 [Abstract] [Full Text] [Related]
36. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA. Bone; 2006 May 10; 38(5):678-85. PubMed ID: 16309985 [Abstract] [Full Text] [Related]
37. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY. Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627 [Abstract] [Full Text] [Related]
38. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH. Exp Cell Res; 2004 Aug 15; 298(2):359-68. PubMed ID: 15265685 [Abstract] [Full Text] [Related]
39. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M. Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833 [Abstract] [Full Text] [Related]
40. Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation. Rozen N, Ish-Shalom S, Rachmiel A, Stein H, Lewinson D. Bone; 2000 May 13; 26(5):469-74. PubMed ID: 10773586 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]